Literature DB >> 19170758

Nucleo-cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activity.

Frank Herrmann1, Frank O Fackelmayer.   

Abstract

Methylation of arginine residues is a widespread post-translational modification of proteins catalyzed by a family of protein arginine methyltransferases (PRMT), of which PRMT1 is the predominant member in human cells. We have previously described the localization and mobility of PRMT1 in live cells, and found that it shuttles between the nucleus and the cytoplasm depending on the methylation status of substrate proteins. Recently, amino-terminal splicing isoforms of PRMT1 were shown to differ significantly in intracellular localization, the most interesting being splice variant 2 that carries a nuclear export signal in its amino terminus, and is expressed in increased levels in breast cancer cells. We show here that enzymatic activity is required for nucleo-cytoplasmic shuttling of PRMT1v2, as a catalytically inactive mutant highly accumulates in the nucleus and displays altered intranuclear mobility as determined by fluorescence recovery after photobleaching experiments. Our results indicate that nuclear export of PRMT1v2 is dominant over activity-independent nuclear import, but can only occur after activity-dependent release of the enzyme from substrates, suggesting that shuttling of the enzyme provides a dynamic mechanism for the regulation of substrate methylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19170758     DOI: 10.1111/j.1365-2443.2008.01266.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  17 in total

1.  The enzymatic activity of Arabidopsis protein arginine methyltransferase 10 is essential for flowering time regulation.

Authors:  Lifang Niu; Falong Lu; Taolan Zhao; Chunyan Liu; Xiaofeng Cao
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

2.  Clinical evaluation of PRMT1 gene expression in breast cancer.

Authors:  Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Journal:  Tumour Biol       Date:  2011-01-13

3.  Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.

Authors:  Bolag Altan; Takehiko Yokobori; Munenori Ide; Erito Mochiki; Yoshitaka Toyomasu; Norimichi Kogure; Akiharu Kimura; Keigo Hara; Tuya Bai; Pinjie Bao; Masaki Suzuki; Kyoichi Ogata; Takayuki Asao; Masahiko Nishiyama; Tetsunari Oyama; Hiroyuki Kuwano
Journal:  Gastric Cancer       Date:  2015-10-15       Impact factor: 7.370

Review 4.  Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.

Authors:  David F Tough; Huw D Lewis; Inmaculada Rioja; Matthew J Lindon; Rab K Prinjha
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

Review 5.  Role of PRMTs in cancer: Could minor isoforms be leaving a mark?

Authors:  R Mitchell Baldwin; Alan Morettin; Jocelyn Côté
Journal:  World J Biol Chem       Date:  2014-05-26

Review 6.  Protein arginine methyltransferases and cancer.

Authors:  Yanzhong Yang; Mark T Bedford
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

7.  Arginine Methylation Initiates BMP-Induced Smad Signaling.

Authors:  Jian Xu; A Hongjun Wang; Juan Oses-Prieto; Kalpana Makhijani; Yoko Katsuno; Ming Pei; Leilei Yan; Y George Zheng; Alma Burlingame; Katja Brückner; Rik Derynck
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

8.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

9.  PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.

Authors:  Hsin-Wei Liao; Jung-Mao Hsu; Weiya Xia; Hung-Ling Wang; Ying-Nai Wang; Wei-Chao Chang; Stefan T Arold; Chao-Kai Chou; Pei-Hsiang Tsou; Hirohito Yamaguchi; Yueh-Fu Fang; Hong-Jen Lee; Heng-Huan Lee; Shyh-Kuan Tai; Mhu-Hwa Yang; Maria P Morelli; Malabika Sen; John E Ladbury; Chung-Hsuan Chen; Jennifer R Grandis; Scott Kopetz; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.

Authors:  Irene Guendel; Lawrence Carpio; Caitlin Pedati; Arnold Schwartz; Christine Teal; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.